Key GOP House members are signaling cautious support for the Senate Finance Committee’s bipartisan drug pricing plan after a meeting between HHS Secretary Alex Azar, House Republicans and Senate Finance Chair Chuck Grassley (R-IA) on Thursday (Sept. 19). However, a provision that would make drug makers pay back Medicare for price hikes that outpace inflation could still prove to be a thorny issue for Republicans. The meeting happened the same day that House Speaker Nancy Pelosi (D-CA) unveiled her sweeping...